Identity and synonyms
Catalog label is recorded; analytical identity and equivalence are not established.
Nonpeptide agent · Vitamin or precursor
Detailed molecular class: Nonpeptide agent; see mechanism for subtype
Supplied sequence or chemical reference
PubChem CID: 493570
Molecular formula: C17H20N4O6
IUPAC: 7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione
Source: PC-RIBOFLAVIN
Database chemical reference; does not certify supplier vial, salt, isomer or formulation.
Mechanism
Vitamin B2/FMΝ and FAD precursor; neither a peptide nor energy itself.
Evidence and critical reading
Reported scientific and empirical uses
Replacement and nutritional context
Nutrition/some studied supplement uses such as migraine; presence in a blend does not verify hair benefit.
Human evidence
Indication/route evidence must remain separate. No skin/nail injectable regimen was assigned from dietary requirements.
Preclinical evidence
Do not equate mechanism, cell culture or animal work with a clinical outcome. The specific level is detailed in the evidence assessment.
Critical reading and limitations
Indication/route evidence must remain separate. No skin/nail injectable regimen was assigned from dietary requirements.
Indication/route evidence must remain separate. No skin/nail injectable regimen was assigned from dietary requirements.
Source-specific regimens
Descriptive source observations, not individual recommendations.
Regulatory product labeling
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Human-study exposure
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Empirical handbook
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Regulation and safety
Jurisdiction-specific regulatory context
This record does not verify FDA/EMA authorization of the commercial identity. Where a specific medicine/product exists, jurisdiction/indication are detailed in cited sources; they do not transfer to supplier material.
Adverse effects and unknowns
A wide nutritional margin does not certify sterility, excipients or supplier-formulation compatibility.
Contraindications
A complete list must match the exact authorized product. For experimental materials without verified human labeling, a complete contraindication set is not established here. No list does not mean safety.
Interactions
Separate documented interaction, pharmacologic plausibility and unknown interaction. Absence of a blend trial does not establish compatibility.
Studies and trials
Selected studies
No selected studies are attributed in this record.
Trials attributed in the package
No trials are attributed in this record.
Trial registration does not establish efficacy or validate commercial material.
Query candidates; attribution pending
Riboflavin · 351 unfiltered query results, not authenticated trials
Query verification: October 16, 2026
Exact phrase intervention query; first three most recently updated records, not exhaustive. Aliases may be missed and heterogeneous products may appear. The total is the unfiltered registry query count, not authenticated trials. Source-integrity holds are excluded from ordinary listings.
View trial registry queryNCT07752342 · Exploring Wellbeing Outcomes in Adolescents Using Bifidobacterium Longum, 1714™Registry status: Not yet recruitingLast update posted: October 14, 2026Query verification: October 16, 2026
NCT07529444 · Microbiological Evaluation of the Effectiveness of Different Surface Decontamination Protocols for Dental ImplantsRegistry status: RecruitingLast update posted: October 2, 2026Query verification: October 16, 2026
NCT01665378 · Impact of Pre-pregnancy Micronutrient Supplementation on Maternal and Child OutcomesRegistry status: CompletedLast update posted: October 2, 2026Query verification: October 16, 2026
Source issues and references
References include queries and bibliographic handbook attributions; not all are clinical studies. Human review remains pending.
- ODS-RIBOFLAVIN
October 16, 2026
- PC-RIBOFLAVIN
PubChem riboflavin (CID 493570)
October 16, 2026